You've read the deck, you like the founder, and the term sheet lands a number on the table. Before anything else you want a quick read on one thing: is this price sane? Not perfect, not optimal, just within shouting distance of reason. That's a different job from working out what the company is worth, and at this stage it's the more useful one.
This piece is the method, not the mechanism. How early-stage prices actually get set is its own subject, covered in how early-stage startup valuations are set, and the pre-money and post-money definitions live in pre-money vs post-money valuation explained. Here you're running four short checks before you commit. None of them produces a verdict. Together they tell you whether the number deserves a harder look or a raised eyebrow.
You're not pricing the company. You're checking whether someone else's price makes sense.
Why a sanity-check beats a model at this stage
At pre-seed and seed there's almost nothing to model. Revenue is thin or zero, the projections are a founder's best guess, and a discounted cash flow on a six-month-old company is theatre. So you don't derive a price. You take the price you've been handed and ask whether it sits within reason. That is the whole shift: from valuation to verification.
How the number got there is a real subject, and worth understanding, comparable rounds, the founder's leverage, what the lead will accept. How early-stage startup valuations are set covers it. But knowing the mechanism doesn't help you in the room when a term sheet is in front of you and you have a week to decide. What helps is a fast, repeatable read: does this price make sense against what comparable UK rounds look like, against the dilution it implies, and against the stage the company is actually at? Get those three lined up and you've caught most of the obviously-off prices. The rest is judgement, and judgement isn't something a spreadsheet hands you.
Check one: against the benchmark
Start by putting the round's pre-money next to the published UK ranges. The strongest source is the British Business Bank's Small Business Equity Tracker 2025 (full-market data for 2024), which put UK seed pre-money at about £5.6m and the median UK seed round at £1.68m. If the price you're looking at is in that neighbourhood for a comparable company, it's unremarkable. If it's two or three times higher, that's not a red flag on its own, but it's a question you now have to answer.
The figure ranges and what they do and don't capture are gathered in UK pre-seed and seed valuation benchmarks for 2026. Read a benchmark as a distribution, not a target. Plenty of good companies price above the median, for reasons: a hot sector, a proven founder, a competitive round with a strong lead setting the terms. A price outside the normal range isn't disqualifying. A price outside the normal range with no reason offered is the thing to notice. When the gap is large, the burden sits with the round to explain itself, not with you to talk yourself into it.
Check two: the dilution and the round size
The second check is arithmetic the headline number hides. A pre-money valuation only tells you so much; what the founder is actually selling is the round divided by the post-money. Raise £1.5m at £5.6m pre-money and you're looking at roughly 21% sold. The question isn't whether that's high or low in the abstract. It's whether the raise buys a milestone worth the dilution.
So look at the use of funds. A round should buy a clear step up: a product shipped, a revenue threshold crossed, the metric that makes the next raise easier. If £1.5m buys eighteen months of runway to one soft milestone, the price and the plan are out of step, however normal the pre-money looks. The other line worth a glance is the option pool. New options usually come out of the pre-money before you put your cheque in, so a generous pool quietly lowers the effective price the founder is taking and raises the dilution the existing holders wear. None of this tells you to pass. It tells you whether the structure behind the number is coherent, which is exactly what a clean headline figure can hide.
Check three: the AI premium question
If the round is an AI company priced well above the seed norm, the third check is the honest one: you can't tell durable demand from market heat off the price. The British Business Bank found UK AI deals running about 40% larger by size than the market in 2024. That's real money moving, but larger rounds are a fact about deal size, not proof a given price is justified.
The arguments on both sides, named and attributed, are laid out in is AI seed valuation a bubble in 2026?. The point for this check is narrower. When an AI round prices at a steep premium, the premium is doing some of the persuading, and a sanity-check exists to notice when that's happening. You don't have to resolve the bubble debate to read a single round. You do have to be clear-eyed that an above-norm AI price is partly a bet on the category staying hot, and decide whether you're comfortable carrying that bet at this price. Hold the question. Paying the premium on faith because the sector is exciting is the opposite of a sanity-check.
What a sanity-check can't do, and a note on advice
A sanity-check flags the obviously-off. It does not tell you to invest, and it does not tell you to walk away. A round can pass all four checks and still be a poor company, or fail a check and still be the deal of the decade because the price was reflecting something the benchmark can't see. Price is one input among many: team, market, the terms beyond valuation, your own portfolio and conviction. The check narrows the field of questions; it doesn't answer the big one.
That last distinction matters under UK rules. Nothing here is a recommendation to back, pass on, or negotiate any particular round, and a benchmark gap is information, not a verdict. Early-stage companies are among the likeliest investments you can make to lose the lot, and a fair price changes none of that. Confirm the current benchmark figures at the British Business Bank on the day you're reading a round, check the scheme rules in HMRC's guidance for investors, and take FCA-regulated advice before you commit capital. The decision is yours; this is the method for getting to it with your eyes open.
Frequently asked questions
How do I know if a startup valuation is too high?
Compare the round's pre-money to the published UK ranges for the stage, then see whether the gap has a reason. UK seed pre-money sat at about £5.6m in 2024 per the British Business Bank, with the median seed round £1.68m. A price two or three times that isn't automatically too high, but it needs a clear explanation: a hot sector, a proven founder, a competitive round. A large gap with no reason offered is the thing to question. The benchmark ranges are gathered in our UK pre-seed and seed valuation benchmarks for 2026.
What's a fair seed valuation in the UK?
There isn't a single fair number, there's a range. The British Business Bank put UK seed pre-money at about £5.6m and the median seed round at £1.68m for 2024. Treat that as a distribution, not a target: good companies price above and below it for real reasons, and stage, sector and region all move the figure. A fair price is one that sits within reason for a comparable company, not one that hits an exact benchmark.
Should I walk away from an overpriced round?
That's a decision this page won't make for you, because price is only one input. An above-benchmark price can be justified by traction, a strong lead setting the terms, or a competitive round, and a cheap price can sit on a weak company. The sanity-check tells you whether the price needs explaining; whether the explanation satisfies you, alongside the team, the market and the other terms, is your judgement. This is information, not advice.
Do angels negotiate valuation?
Sometimes, at the margin, though less than people expect at seed. In a competitive round with a lead investor already setting the terms, an individual angel often takes the price as offered or passes. Where there's more room, the negotiation is as likely to be about structure, the option pool, the instrument, follow-on rights, as about the headline number. A sanity-check helps you decide whether the price is worth pushing on at all.
Is this valuation sanity-check financial advice?
No. It is general information about a method some UK angels use to read a round, not a recommendation to invest in, pass on, or negotiate any particular deal. Reliefs and rules change with each Budget, market benchmarks shift, and early-stage companies are among the likeliest investments to lose the lot. Confirm current figures at the British Business Bank and HMRC, and take advice from an FCA-regulated adviser before committing capital.